Mark E. Burkard, Ph.D.
Affiliations: | 2000 | University of Rochester, Rochester, NY |
Area:
BiochemistryGoogle:
"Mark Burkard"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Douglas H. Turner | grad student | 2000 | Rochester | |
| (Base stacking interactions and the thermodynamics and structure of guanine -guanine pairs in RNA.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Denu RA, Burkard ME. (2020) Analysis of the "centrosome-ome" identifies MCPH1 deletion as a cause of centrosome amplification in human cancer. Scientific Reports. 10: 11921 |
| Sharick JT, Walsh CM, Sprackling CM, et al. (2020) Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment. Frontiers in Oncology. 10: 553 |
| Singh A, Denu RA, Wolfe SK, et al. (2020) Centrosome amplification is a frequent event in circulating tumor cells from subjects with metastatic breast cancer. Molecular Oncology |
| Parsons BM, Meier DR, Richmond CS, et al. (2020) Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer. Clinical Breast Cancer |
| Emmerich P, Matkowskyj KA, McGregor S, et al. (2020) VCAN accumulation and proteolysis as predictors of T lymphocyte-excluded and permissive tumor microenvironments. Journal of Clinical Oncology. 38: 3127-3127 |
| Rocque G, Gilbert A, Williams CP, et al. (2020) Abstract P2-15-05: Visualization of the relationship between survival and sequential treatments in metastatic breast cancer Cancer Research. 80 |
| Wildiers H, Boni V, Saura C, et al. (2020) Abstract P1-19-08: Neratinib + trastuzumab + fulvestrant for HER2-mutant, hormone receptor-positive, metastatic breast cancer: Updated results from the phase 2 SUMMIT ‘basket’ trial Cancer Research. 80 |
| Hu Y, Jin N, Manasrah BK, et al. (2020) Abstract 2248: Paclitaxel-induced micronucleation activates pro-inflammatory cGAS/STING signaling in triple negative breast cancer Immunology |
| Pasch CA, Favreau PF, Yueh AE, et al. (2019) Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Gilbert A, Kandhare P, Nakhmani A, et al. (2019) Utilizing visualization to qualitatively evaluate electronic health record-derived database limitations. Journal of Clinical Oncology. 37: 317-317 |